A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.
The result of the team’s four-year project is a novel gene therapeutic approach. The work was published (http://stm.sciencemag.org/content/8/348/348ra98) July 20 in Science Translational Medicine, a journal of the American Association for the Advancement of Science.
“Chronic disease affects more than half of the world’s population,” said Rodgers, professor of animal sciences (https://ansci.wsu.edu/people/faculty/dan-rodgers/) and director of the Washington Center for Muscle Biology (http://wcmb.wsu.edu/). “Most of those diseases are accompanied by muscle wasting.
“It occurs with chronic infection, muscular dystrophy, malnutrition and old age,” he said. “About half the people who die from cancer are actually dying from muscle wasting and there’s not one single therapy out there that addresses it.
Family history inspires search for treatment
“I have a strong motivation to do something about this, to do more than simply publish results,” said Rodgers, who teamed with Gregorevic of Baker IDI Heart and Diabetes Institute in Australia (https://www.bakeridi.edu.au/). “My father died from cachexia,” the wasting disease caused by cancer, “and my nephew has Duchenne muscular dystrophy, an incurable, fatal disease that could claim his life in his teens.
“Others have tried and failed to develop treatments for muscle wasting,” Rodgers said, “and some drugs have even caused serious safety problems. Our targeted approach only affects muscle and completely avoids these problems, which is why we think we have a solution.”
In the paper, lead author Catherine Winbanks, a postdoctoral fellow of Gregorevic, details how researchers built muscle in healthy mice and prevented the loss of skeletal and heart muscle in mice with tumors.
Hormone’s muscle-wasting effect blocked
In cachexia, tumors secrete hormones that cause muscle deterioration; in effect, the body eats its own muscles, causing weakness, frailty and fatigue.
“What kills a lot of people isn’t the loss of skeletal muscle but heart muscle,” said Rodgers. “The heart literally shrinks, causing heart failure.”
Researchers have long sought to stop this process, but failed to find a safe way. That’s because the hormones that cause wasting – in particular, a naturally occurring hormone called myostatin – play important roles elsewhere in the body.
Rodgers and Gregorevic needed a way to stop myostatin, but only in muscles. Their solution: an adeno-associated virus – a benign virus that specifically targets heart and skeletal muscle.
The virus delivers a small piece of DNA – a signaling protein called Smad7 – into muscle cells. Smad7 then blocks two signaling proteins called Smad2 and Smad3, which are activated by myostatin and other muscle-wasting hormones. By blocking those signals, Smad7 stops the breakdown of muscles.
“Smad7 is the body’s natural break and, by inhibiting the inhibitor, you build muscle,” Rodgers said.
For cachexia patients, such a therapy could massively increase their chances of survival.
“Instead of having one year to fight cancer, you’d have 10 or 15,” Rodgers said.
Startup works to develop commercial drug
In 2015, Rodgers launched AAVogen, a company that will develop this discovery into a commercial drug, AVGN7.
He has been working with Norman Ong, a technology licensing associate at WSU’s Office of Commercialization, on patents, startup funding and recruitment for AAVogen. Using the funds from WSU’s commercial gap fund award, Rodgers’ lab will determine the minimum effective dose for AVGN7.
“We want to turn WSU discoveries into real-world uses that benefit the public,” said Ong. “Dan is a very busy scientist, so we’re proud to help him and AAVogen connect with the right people.”
“I formed this company for one purpose: to move the science into society, to see it applied,” Rodgers said. “WSU’s Office of Commercialization has been instrumental and invaluable to this endeavor.
“Now we have a company with the potential to save a lot of lives,” he said.
The Latest on: Muscle wasting
via Google News
The Latest on: Muscle wasting
- Q&A: U of M’s Michael Osterholm calls for national leadership to address CWDon August 16, 2019 at 7:18 am
Chronic wasting disease (CWD) is a progressive and degenerative brain ... And unless that material got into the meat, the actual muscle of the animal, the risk [of infection] was very low because ...
- Copperas Cove family using their story to highlight spinal muscular atrophyon August 15, 2019 at 4:55 pm
"My muscles don't work like everyone else," said Sawyer. Doctors say one in every 40 people carries the gene that causes SMA, and a child of two gene-carriers has a 25% chance of being born with ...
- 5 Ways to Avoid Age-Related Muscle Losson August 14, 2019 at 9:18 pm
In addition to weight-resistance training, adding daily walks into your routine will help you keep your muscles active so you slow down the atrophy that comes with a more sedentary lifestyle. A walk ...
- How to build muscle and tone your armson August 13, 2019 at 12:00 am
Last week we told you how to build muscle in your legs – and today we ... so if you spend hours doing hundreds of biceps curls then you’ll be wasting a lot of energy.
- Family in Kingsford brings awareness to Spinal Muscular Atrophyon August 12, 2019 at 3:38 pm
(WLUC) - August is Spinal Muscular Atrophy awareness month ... SMA is a genetic disease that affects parts of the nervous system which controls voluntary muscle movement. "It's the number one genetic ...
- Protein that causes muscle weakness identified: Know the reasons behind this conditionon August 9, 2019 at 6:37 am
a condition that involves weakness and slowly progressive wasting of voluntary muscles in the face, neck, and lower arms and legs. It is a type of poisoning caused by Clostridium botulinum bacteria.
- New improved model for cancer wasting syndrome cachexiaon August 7, 2019 at 7:23 am
Cachexia refers to the excessive weight loss and the characteristic wasting due to loss of skeletal muscle, seen in at least half advanced cancers. It is often associated with systemic inflammation ...
- Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular diseaseon August 6, 2019 at 2:17 am
Our results demonstrate the potential of ACE-083 as a therapeutic agent for patients with CMT, muscular dystrophy and other disorders with focal or asymmetric muscle atrophy or weakness. ACE-083 is a ...
- Do Amino Acids Build Bigger Muscles?on August 3, 2019 at 6:05 am
People who don’t have access to sufficient amounts of protein can experience muscle atrophy and muscle wasting. The US Recommended Daily Allowance (RDA) for protein is 0.36 grams per pound. You’ve ...
- UWindsor prof gets CIBC funding to "put the brakes on" muscle wastingon August 1, 2019 at 5:01 pm
The currently untreatable muscle wasting condition responsible for one in five cancer deaths has a new team of Windsor researchers trying to unpack it. Thanks to $100,000 in funding from CIBC ...
via Bing News